Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR was delisted on the 14th of February, 2025.
28 hedge funds and large institutions have $838K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
17% more funds holding
Funds holding: 24 → 28 (+4)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
30% less capital invested
Capital invested by funds: $1.2M → $838K (-$367K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$48.5K |
| 2 |
Walleye Capital
New York
|
+$27.2K |
| 3 |
HCM
Highbridge Capital Management
New York
|
+$16.2K |
| 4 |
Walleye Trading
New York
|
+$15.3K |
| 5 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$7.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOA
Sea Otter Advisors
Miami,
Florida
|
-$28.1K |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$23K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$9.7K |
| 4 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$6.71K |
| 5 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$4.97K |
BLACR Hedge Fund Activity: Q4 2023 in Review
28 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Rights (BLACR) for Q4 2023, worth a combined $838K — down 30% from $1.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BLACR positions and 4 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $48.5K. The largest seller was Sea Otter Advisors, exiting entirely with an estimated $28.1K sold.
- 28 institutional investors held Bellevue Life Sciences Acquisition Corp. Rights (BLACR) as of Q4 2023, up from 24 in Q3 2023.
- Funds reported $838K of Bellevue Life Sciences Acquisition Corp. Rights stock for Q4 2023, down 30% quarter-over-quarter.
- 8 funds opened new Bellevue Life Sciences Acquisition Corp. Rights positions in Q4 2023 and 4 closed out, a net change of +4 holders.
- The largest Bellevue Life Sciences Acquisition Corp. Rights buyer in Q4 2023 was JP Morgan Chase, an estimated $48.5K added.
- The largest Bellevue Life Sciences Acquisition Corp. Rights seller in Q4 2023 was Sea Otter Advisors, an estimated $28.1K sold.
Based on aggregated 13F filings for Q4 2023.